Loading...
Bioventus Q1 2025 Earnings Report
Bioventus reported its first quarter financial results, with revenue declining 4.3% but organic revenue advancing 5.0%.
Key Takeaways
Bioventus reported a first-quarter net loss of $2.6 million, or $0.04 per share, on revenue of $123.9 million. Despite a decline in reported revenue, organic revenue increased by 5.0%. The company reiterated its full-year 2025 financial guidance.
Q1 reported revenue was $123.9 million, a 4.3% decline from the prior year.
Organic revenue advanced 5.0% due to positive organic growth across all three businesses.
Net loss was $0.04 per share, an improvement from a $0.08 loss in the prior-year period.
Non-GAAP earnings per share increased 33% to $0.08.
Bioventus
Bioventus
Bioventus Revenue by Segment
Bioventus Revenue by Geographic Location
Revenue by Segment
Pain Treatments Revenue
CapyFin.comSurgical Solutions Revenue
CapyFin.comRestorative Therapies Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Bioventus reiterated its 2025 financial guidance, expecting net sales between $560 million and $570 million and Adjusted EBITDA between $112 million and $116 million.
Positive Outlook
- Net sales expected to be between $560 million and $570 million.
- Organic growth of approximately 6.1% to 8.0% included in net sales guidance.
- Adjusted EBITDA expected to be between $112 million and $116 million.
- Adjusted EBITDA Margin growth of 100 basis points compared to 2024.
- Non-GAAP EPS expected to increase by 30.6% to 38.8% ($0.64 to $0.68).
Challenges Ahead
- The guidance includes an estimated immaterial impact of tariffs.
- The company is unable to provide U.S. GAAP financial measures on a forward-looking basis due to uncertainties.
- Acquisition and divestiture related expenses are uncertain and could be material.
- Accounting fair-value adjustments are uncertain and could be material.
- Certain other reconciling items are uncertain and could be material.
Revenue & Expenses
Visualization of income flow from segment revenue to net income